article thumbnail

4th Antigen Specific Immune Tolerance Summit

pharmaphorum

The 4 th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. The post 4th Antigen Specific Immune Tolerance Summit appeared first on.

article thumbnail

First nasal monoclonal antibody COVID-19 treatment shows potential

European Pharmaceutical Review

Findings from research on the nasal monoclonal antibody “Based on our studies, we expect that Foralumab may work on all variants as it acts on immune effects,” Dr Weiner continued. Foralumab’s immune modulating response In 2020, Moreira researched how Foralumab modulates the immune response to reduce inflammation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4th Inflammasome Therapeutics Summit 2022

pharmaphorum

Here’s a snapshot of the senior experts set to be attending: Hao Wu , Asa & Patricia Springer Professor, Boston Children’s Hospital & Harvard Medical School. Marc Pelletier , Senior Principal Scientist – Translational Immune Oncology, Novartis. Alan Watt , Chief Scientific Officer, NodThera.

article thumbnail

How Do You Become an Anesthesiologist?  

Board Vitals - Pharmacist

Most paths to becoming an anesthesiologist take around 12 years to complete, which includes 4 years of an undergraduate program, four years of medical school, 4-5years of residency training in anesthesiology, and typically followed by 1-2 years in a fellowship subspecialty training. How long does it take to become an anesthesiologist?

article thumbnail

TIGIT Therapies 2021

pharmaphorum

Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology. David Hafler, Yale School of Medicine. Vijay Kuchroo, Harvard Medical School and Brigam & Women’s Hospital. Walter Fiedler and Franziska Brauneck, University Medical Center Hamburg-Eppendorf.

article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

Finally, Andreas looks at the prospects for antibodies that target the innate immune system in treating both haematological malignancies and solid tumours. Many cancer patients, however, lack a functional innate immune system, and do not have enough functional NK cells. Dr Harstrick received his M.D.

article thumbnail

What Do You Need to Know About ABFM Family Medicine Certification? 

Board Vitals - Pharmacist

Family Medicine physicians deliver comprehensive, preventive and continuous care across the age span and for a variety of acute and chronic medical conditions. How do I become board certified in Family Medicine? .